Phase 2 RCT in 100 patients with uncomplicated malaria in Gabon and Ghana, reporting secondary endpoints: PCR-corrected day-42 cure was 87.5% with standard artesunate-pyronaridine, 85.3% with APAP and 94.4% with AFC, with no evidence of differing efficacy; all were safe.
RCTn = 100
Agobé et al. Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana